A 70-year-old male was admitted to the Hubei Cancer Hospital with complaints of left-sided limb weakness and numbness persisting for one month after completing the first cycle of albumin paclitaxel, cisplatin, and tislelizumab treatment for right-sided NSCLC in December 2021. The gene discussed is ALB; the disease is cancer.